<DOC>
	<DOCNO>NCT00418262</DOCNO>
	<brief_summary>Determine atomoxetine safe well tolerated child fetal alcohol syndrome .</brief_summary>
	<brief_title>Open-Label Study Long Term Tolerability Safety Atomoxetine Children With FASD ADD/ADHD</brief_title>
	<detailed_description>Abnormalities attention , function , activity level child expose alcohol utero share similarity differences child alcohol exposure . Previous psychological study examine either core attention deficit hyperactivity ( ADHD ) symptoms hyperactivity , inattention , impulsivity hypothesize neuropsychological difference child fetal alcohol syndrome ( FAS ) ADHD . Atomoxetine Hydrochloride non-stimulant medication use treat ADHD . This study determine atomoxetine HCL significantly reduce symptom ADD/ADHD child fetal alcohol exposure .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Fetal Alcohol Spectrum Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patient must age 4 11 year time entry double blind study . Patients must meet diagnostic criterion FASD . Patient must , entry doubleblind study , meet DSMIV criterion ADHD , subtype . And must ADHDRSIV score &gt; + 90 % age gender either subtest total score child 5 year age . Patients continue atomoxetine/placebo entry nto study . History physical exam must reveal clinically significant abnormality would preclude safe participation study . Patients must able swallow capsule . Patients must sufficient mental age ( 3 yr ) participate study . Patients parent must able communicate effectively investigator coordinator judge reliable keep appointment participate data collection . Teacher must agree cooperate study . Have receive investigational medication atomoxetine previous 30 day . Have significant current medical condition could exacerbate compromised atomoxetine . Have use MAOIs within one month prior visit 1 . Patients hypertension . Patients previous diagnosis bipolar disorder , psychosis , autism spectrum disorder . Patients take anticonvulsant seizure control . Patients take another psychotropic medication health food supplement purport central nervous system activity within 5 halflives visit 1 . Patients Tourette Disorder neurological condition would interfere ability receive treatment comply monitoring . Pubertal girl .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>fetal alcohol syndrome</keyword>
	<keyword>attention deficit disorder</keyword>
	<keyword>attention deficit disorder hyperactivity</keyword>
	<keyword>ADD</keyword>
	<keyword>FAS</keyword>
	<keyword>FASD</keyword>
	<keyword>ADHD</keyword>
</DOC>